Literature DB >> 19083027

Mechanism of zinc(II)-promoted amyloid formation: zinc(II) binding facilitates the transition from the partially alpha-helical conformer to aggregates of amyloid beta protein(1-28).

Christine Talmard1, Rodrigue Leuma Yona, Peter Faller.   

Abstract

The amyloidoses are a group of disorders characterized by aberrant protein folding and assembly, leading to the deposition of insoluble protein fibrils (amyloid), which provokes cell dysfunction and later cell death. One of the physiologically relevant environmental factors able to affect the conformation and hence the aggregation properties of amyloidogenic proteins/peptides is metal ions. Zn(II) promotes aggregation of most amyloidogenic peptides/proteins in vitro, including amyloid beta protein (Abeta), but the underlying mechanism is not known. To better understand this mechanism the present study focused on the partially alpha-helical conformer, supposed to be an intermediate in Abeta aggregation. This partially alpha-helical conformer is stabilized by 10-20% 2,2,2-trifluoroethanol (TFE): therefore, the influence of Zn binding on the aggregation of the amylidogenic model peptide Abeta(1-28) (Abeta28) was investigated at different TFE concentrations. The results showed a synergistic effect of Zn(II) and 10% TFE, i.e., that either Zn or 10% TFE accelerated Abeta28 aggregation on its own, but with them together an at least 10 times promotion of Abeta28 aggregation was observed. Further studies by thioflavin T fluorescence spectroscopy, transmission electron microscopy, and circular dichroism (CD) spectroscopy suggested that the aggregates of Zn-Abeta28 formed in 10%TFE contain a beta-sheet secondary structure and are more of the amyloid type. CD spectroscopy indicated that Zn binding disrupted partially the alpha-helical structure of Abeta28 in TFE. Thus, we propose that the promotion of Abeta28 aggregation by Zn is based on the transformation of the partially alpha-helical conformer (intermediate) towards the beta-sheet amyloid structure by a destabilization of the alpha-helix in the intermediate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19083027     DOI: 10.1007/s00775-008-0461-9

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  48 in total

1.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

Authors:  D M Walsh; D M Hartley; Y Kusumoto; Y Fezoui; M M Condron; A Lomakin; G B Benedek; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

2.  Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid {beta} peptide.

Authors:  Bakthisaran Raman; Tadato Ban; Kei-Ichi Yamaguchi; Miyo Sakai; Tomoji Kawai; Hironobu Naiki; Yuji Goto
Journal:  J Biol Chem       Date:  2005-02-16       Impact factor: 5.157

3.  Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes.

Authors:  T Miura; K Suzuki; N Kohata; H Takeuchi
Journal:  Biochemistry       Date:  2000-06-13       Impact factor: 3.162

Review 4.  Therapeutic strategies for human amyloid diseases.

Authors:  James C Sacchettini; Jeffery W Kelly
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

5.  Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.

Authors:  Vello Tõugu; Ann Karafin; Peep Palumaa
Journal:  J Neurochem       Date:  2008-03       Impact factor: 5.372

6.  NMR studies of the Zn2+ interactions with rat and human beta-amyloid (1-28) peptides in water-micelle environment.

Authors:  Elena Gaggelli; Anna Janicka-Klos; Elzbieta Jankowska; Henryk Kozlowski; Caterina Migliorini; Elena Molteni; Daniela Valensin; Gianni Valensin; Ewa Wieczerzak
Journal:  J Phys Chem B       Date:  2007-12-12       Impact factor: 2.991

Review 7.  Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.

Authors:  Charles G Glabe
Journal:  Neurobiol Aging       Date:  2006-02-14       Impact factor: 4.673

8.  Stabilization of neurotoxic soluble beta-sheet-rich conformations of the Alzheimer's disease amyloid-beta peptide.

Authors:  Deborah J Tew; Stephen P Bottomley; David P Smith; Giuseppe D Ciccotosto; Jeffrey Babon; Mark G Hinds; Colin L Masters; Roberto Cappai; Kevin J Barnham
Journal:  Biophys J       Date:  2007-12-07       Impact factor: 4.033

Review 9.  Amyloidosis.

Authors:  Mark B Pepys
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

10.  Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease.

Authors:  Christopher D Syme; John H Viles
Journal:  Biochim Biophys Acta       Date:  2005-10-14
View more
  12 in total

1.  Role of zinc in human islet amyloid polypeptide aggregation.

Authors:  Jeffrey R Brender; Kevin Hartman; Ravi Prakash Reddy Nanga; Nataliya Popovych; Roberto de la Salud Bea; Subramanian Vivekanandan; E Neil G Marsh; Ayyalusamy Ramamoorthy
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

Review 2.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.

Authors:  Colin L Masters; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

3.  Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-06       Impact factor: 11.205

4.  Substantial contribution of the two imidazole rings of the His13-His14 dyad to Cu(II) binding in amyloid-β(1-16) at physiological pH and its significance.

Authors:  Byong-kyu Shin; Sunil Saxena
Journal:  J Phys Chem A       Date:  2011-04-14       Impact factor: 2.781

5.  The biofilm adhesion protein Aap from Staphylococcus epidermidis forms zinc-dependent amyloid fibers.

Authors:  Alexander E Yarawsky; Stefanie L Johns; Peter Schuck; Andrew B Herr
Journal:  J Biol Chem       Date:  2020-02-26       Impact factor: 5.157

6.  Metal ion binding to anticoagulation factor II from the venom of Agkistrodon acutus: stabilization of the structure and regulation of the binding affinity to activated coagulation factor X.

Authors:  Dengke Shen; Xiaolong Xu; Hao Wu; Lili Peng; Yan Zhang; Jiajia Song; Qingde Su
Journal:  J Biol Inorg Chem       Date:  2011-01-01       Impact factor: 3.358

7.  Quantification of the binding properties of Cu2+ to the amyloid beta peptide: coordination spheres for human and rat peptides and implication on Cu2+-induced aggregation.

Authors:  Lian Hong; Tessa M Carducci; William D Bush; Christopher G Dudzik; Glenn L Millhauser; John D Simon
Journal:  J Phys Chem B       Date:  2010-09-02       Impact factor: 2.991

Review 8.  Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Chem Rev       Date:  2010-08-11       Impact factor: 60.622

Review 9.  Importance and management of micronutrient deficiencies in patients with Alzheimer's disease.

Authors:  Bárbara Rita Cardoso; Cristiane Cominetti; Silvia Maria Franciscato Cozzolino
Journal:  Clin Interv Aging       Date:  2013-05-10       Impact factor: 4.458

10.  Molecular dynamics study of Zn(aβ) and Zn(aβ)2.

Authors:  Lurong Pan; James C Patterson
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.